Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus Sandimmun® Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplants

Gäckler, Anja; Dolff, Sebastian; Rohn, Hana; Korth, Johannes; Wilde, Benjamin; Eisenberger, Ute; Mitchell, Anna; Kribben, Andreas; Witzke, Oliver

doi:10.1186/s12882-019-1340-z

BMC Nephrology

Article metrics
Last updated: Wed, 24 Apr 2024 12:12:36 Z

Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus Sandimmun® Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplants

Access & Citations

1847

Article Accesses
2

Web of Science
3

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2369

Contact us

Submission enquiries: bmcnephrology@biomedcentral.com
General enquiries: ORSupport@springernature.com